Schlagwort: Life Sciences

Cologne-based biotech start-up Disco Pharmaceuticals is taking a new approach to cancer therapy: using innovative cell-surface mapping to develop selective cancer therapeutics. Malignant cells carry...

Personalised cancer therapies have long been considered one of medicine’s most promising frontiers. Recent clinical results from Merck and Moderna involving mRNA-based approaches have...

The landscape for radiopharmaceutical therapies in oncology is evolving rapidly, propelled by early commercial successes and an expanding clinical pipeline. Yet realising the full...

Artificial intelligence in healthcare requires more than speed AI is rapidly transforming healthcare, helping organisations work more efficiently across administrative and clinical functions. Yet one...

Radiopharmacy is on the path to becoming a huge market for treatment opportunities. For start-ups, regional clusters and networks are the key for attracting...

Rhineland-Palatinate fostered its position as a leading biotech location. The Life Science Zentrum Mainz (LZM) connects science, start-ups, and industry through its business units...

Da ein schneller Zugang zu spezialisierter Infrastruktur entscheidend für den Transfer biotechnologischer Forschung in den Markt ist, haben CIC Catalyst und die Cellcolab GmbH...

Gilead’s acquisition of Munich-based Tubulis earlier this year has put German antibody-drug conjugate (ADC) innovation into the global spotlight. With a total deal value...

When a single internal, non-invasive sensing platform can continuously capture physiological data from an athlete during training/game and simultaneously monitor a special forces operator’s...

AI only transforms medicine once innovations reach the point of care. The Hannover region offers strong foundations for this: research, clinical care, business, and...

German research institutions produce world-class science, yet university spin-offs continue to face a practical bottleneck: securing intellectual property (IP) on terms that founders and...

The fourth Edition of the Biotech Summit Austria brought together leading voices from research, industry, startups, investment and policy in Innsbruck this week. Jointly...

VC Magazin: How do you currently assess the position of the DACH region within the international life sciences ecosystem  and where do you see...

A tranche payment that is conditional on the achievement of specific milestones is a common instrument in venture capital financing for life sciences because...

Coal and steel have shaped Dortmund’s history – science and innovation are in- creasingly shaping its future. In the wake of structural change, a...